236 related articles for article (PubMed ID: 8206104)
1. The 5' boundary of somatic hypermutation in a V kappa gene is in the leader intron.
Rada C; González-Fernández A; Jarvis JM; Milstein C
Eur J Immunol; 1994 Jun; 24(6):1453-7. PubMed ID: 8206104
[TBL] [Abstract][Full Text] [Related]
2. The 5' hypermutation boundary of kappa chains is independent of local and neighbouring sequences and related to the distance from the initiation of transcription.
Rada C; Yélamos J; Dean W; Milstein C
Eur J Immunol; 1997 Dec; 27(12):3115-20. PubMed ID: 9464795
[TBL] [Abstract][Full Text] [Related]
3. Position of the rearranged V kappa and its 5' flanking sequences determines the location of somatic mutations in the J kappa locus.
Weber JS; Berry J; Manser T; Claflin JL
J Immunol; 1991 May; 146(10):3652-5. PubMed ID: 1902859
[TBL] [Abstract][Full Text] [Related]
4. Somatic hypermutation of the JC intron is markedly reduced in unrearranged kappa and H alleles and is unevenly distributed in rearranged alleles.
Weber JS; Berry J; Litwin S; Claflin JL
J Immunol; 1991 May; 146(9):3218-26. PubMed ID: 1901897
[TBL] [Abstract][Full Text] [Related]
5. Somatic hypermutation of an immunoglobulin transgene in kappa transgenic mice.
O'Brien RL; Brinster RL; Storb U
Nature; 1987 Mar 26-Apr 1; 326(6111):405-9. PubMed ID: 3104790
[TBL] [Abstract][Full Text] [Related]
6. Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted V kappa gene utilization, junctional V kappa J kappa and V lambda J lambda diversity, and somatic hypermutation.
Ikematsu W; Kobarg J; Ikematsu H; Ichiyoshi Y; Casali P
J Immunol; 1998 Sep; 161(6):2895-905. PubMed ID: 9743351
[TBL] [Abstract][Full Text] [Related]
7. Somatic hypermutation of Ig genes is affected differently by failures in apoptosis caused by disruption of Fas (lpr mutation) or by overexpression of Bcl-2.
Mastache EF; Lindroth K; Fernández C; González-Fernández A
Scand J Immunol; 2006 Jun; 63(6):420-9. PubMed ID: 16764695
[TBL] [Abstract][Full Text] [Related]
8. Non-random features of the repertoire expressed by the members of one V kappa gene family and of the V-J recombination.
Milstein C; Even J; Jarvis JM; Gonzalez-Fernandez A; Gherardi E
Eur J Immunol; 1992 Jun; 22(6):1627-34. PubMed ID: 1601044
[TBL] [Abstract][Full Text] [Related]
9. Mutations in Ig V(D)J genes are distributed asymmetrically and independently of the position of V(D)J.
Weber JS; Berry J; Manser T; Claflin JL
J Immunol; 1994 Oct; 153(8):3594-602. PubMed ID: 7930582
[TBL] [Abstract][Full Text] [Related]
10. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.
Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL
Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167
[TBL] [Abstract][Full Text] [Related]
11. Somatic hypermutation in 5' flanking regions of heavy chain antibody variable regions.
Rothenfluh HS; Taylor L; Bothwell AL; Both GW; Steele EJ
Eur J Immunol; 1993 Sep; 23(9):2152-9. PubMed ID: 8370398
[TBL] [Abstract][Full Text] [Related]
12. Influence of a V kappa 8 L chain transgene on endogenous rearrangements and the immune response to the HA(Sb) determinant on influenza virus.
Carmack CE; Camper SA; Mackle JJ; Gerhard WU; Weigert MG
J Immunol; 1991 Sep; 147(6):2024-33. PubMed ID: 1909739
[TBL] [Abstract][Full Text] [Related]
13. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human.
Küppers R; Hajadi M; Plank L; Rajewsky K; Hansmann ML
Eur J Immunol; 1996 Aug; 26(8):1794-800. PubMed ID: 8765023
[TBL] [Abstract][Full Text] [Related]
14. V gene rearrangement is required to fully activate the hypermutation mechanism in B cells.
Roes J; Hüppi K; Rajewsky K; Sablitzky F
J Immunol; 1989 Feb; 142(3):1022-6. PubMed ID: 2492327
[TBL] [Abstract][Full Text] [Related]
15. Somatic hypermutation of an artificial test substrate within an Ig kappa transgene.
Klotz EL; Hackett J; Storb U
J Immunol; 1998 Jul; 161(2):782-90. PubMed ID: 9670955
[TBL] [Abstract][Full Text] [Related]
16. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
[TBL] [Abstract][Full Text] [Related]
17. Lack of somatic mutation in a kappa light chain transgene.
Sharpe MJ; Neuberger M; Pannell R; Surani MA; Milstein C
Eur J Immunol; 1990 Jun; 20(6):1379-85. PubMed ID: 2115000
[TBL] [Abstract][Full Text] [Related]
18. A reporter gene to analyse the hypermutation of immunoglobulin genes.
Chui YL; Lozano F; Jarvis JM; Pannell R; Milstein C
J Mol Biol; 1995 Jun; 249(3):555-63. PubMed ID: 7783211
[TBL] [Abstract][Full Text] [Related]
19. Characterization of allelic V kappa-1 region genes in inbred strains of mice.
Ng KH; Lavigueur A; Ricard L; Boivrette M; Maclean S; Cloutier D; Gibson DM
J Immunol; 1989 Jul; 143(2):638-48. PubMed ID: 2567773
[TBL] [Abstract][Full Text] [Related]
20. Genes encoding Xenopus laevis Ig L chains. Implications for the evolution of kappa and lambda chains.
Zezza DJ; Stewart SE; Steiner LA
J Immunol; 1992 Dec; 149(12):3968-77. PubMed ID: 1460285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]